Concepedia

MacLean Hall

MH

Statistics

Publications

13

Citations

1.2K

H-Index

11

Active since

2010

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

NYU Langone Health

Massachusetts General Hospital

MacLean Hall is an author at Moffitt Cancer Center specializing in cancer immunotherapy, oncology, and immunology.

ORCID

Publications per year

2010–2023

13

Publications

13

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

Kim H.T. Paraiso, Inna V. Fedorenko, Liliana Cantini et al. · British Journal of Cancer · 2010 · 313 citations · Full text

, , +15

Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

Amod A. Sarnaik, Bin Yu, Daohai Yu et al. · Clinical Cancer Research · 2010 · 200 citations · Full text

, , +17

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors

MacLean Hall, Hao Liu, Mokenge P. Malafa et al. · Journal for ImmunoTherapy of Cancer · 2016 · 163 citations · Full text

, , +17

Biomarkers on melanoma patient T Cells associated with ipilimumab treatment

Wenshi Wang, Daohai Yu, Amod A. Sarnaik et al. · Journal of Translational Medicine · 2012 · 118 citations · Full text

, , +17

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran et al. · Frontiers in Oncology · 2018 · 97 citations · Full text

, , +17

1–5 of 13